Provided by Tiger Trade Technology Pte. Ltd.

Vincera Pharma, Inc.

0.0125
0.0000
Volume:412.00
Turnover:5.15
Market Cap:65.43K
PE:0.00
High:0.0125
Open:0.0125
Low:0.0125
Close:0.0125
52wk High:1.43
52wk Low:0.0002
Shares:5.23M
Float Shares:4.94M
Volume Ratio:0.03
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.9799
EPS(LYR):-15.8451
ROE:-3136.43%
ROA:-197.53%
PB:0.03
PE(LYR):0.00

Loading ...

Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote for Approval of Dissolution Proposal

THOMSON REUTERS
·
Jul 17, 2025

Vincerx Pharma, Inc. Urges Stockholders to Vote for Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders

THOMSON REUTERS
·
Jul 08, 2025

Press Release: Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders

Dow Jones
·
Jul 08, 2025

Vincerx Pharma Q1 EPS $(1.40) Up From $(11.60) YoY

Benzinga
·
May 16, 2025

BRIEF-Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC

Reuters
·
Apr 18, 2025

Vincerx Pharma Plans Delisting After Nasdaq Suspends Trading

MT Newswires Live
·
Apr 18, 2025

Vincerx Pharma, Inc. Announces Intent to Delist From Nasdaq and Deregister With the SEC

THOMSON REUTERS
·
Apr 18, 2025

Vincerx Pharma Inc - Stock to Resume Trading on April 21, 2025

THOMSON REUTERS
·
Apr 18, 2025

Vincerx Pharma Inc - Board Decides to Dissolve, Liquidate, and Wind-up Business

THOMSON REUTERS
·
Apr 18, 2025

Crude Oil Down 4%; Neogen Shares Plunge After Q3 Results

Benzinga
·
Apr 10, 2025

Vincerx Pharma Begins Wind-Down After Terminating Merger Plan With QumulusAI

MT Newswires Live
·
Apr 09, 2025

Vincerx Terminates Merger Attempt, Initiates Wind-Down

Dow Jones
·
Apr 09, 2025

BRIEF-Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities

Reuters
·
Apr 09, 2025

Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities

THOMSON REUTERS
·
Apr 09, 2025

Vincerx Pharma - Board Authorizes to Continue Asset Monetization & Out-Licensing Opportunities

THOMSON REUTERS
·
Apr 09, 2025

Press Release: Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities

Dow Jones
·
Apr 09, 2025

Vincerx Pharma Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 28, 2025

Vincerx Pharma Inc expected to post a loss of $3.40 a share - Earnings Preview

Reuters
·
Mar 25, 2025